FOXM1 and cancer: In fact, WDR5 also interacts with MYC, a well-known oncoprotein broadly overexpressed in some cancers, through its WBM site to promote tumorigenesis [23], and other proteins through its WIN site and these interactions are extensively reported to be involved in tumor progression [40, 41].